Clinical Trials Arena December 6, 2023
The collaboration focuses on the evaluation of real-world data study designs and methods for informing regulatory objectives.
The US Food and Drug Administration (FDA) has renewed a four-year collaboration agreement between its Oncology Center of Excellence and Syapse, a real-world-data-focused healthcare company.
The collaboration focuses on the evaluation of real-world data (RWD) study designs and methods, which the partners hope will allow for an exploration of the potential uses of RWD in informing regulatory objectives.
The previous partnership focused on real-world health disparities, examining the impact of Covid-19 on cancer patients and the incidence of pneumonitis – non-infectious lung inflammation – in lung cancer patients.
Syapse uses its artificial intelligence (AI)-enhanced data platform Raydar to process large swathes of RWD...
Today's Sponsors
Today's Sponsor
